| Entry |
|
|---|
| Name |
Triaziquone (INN) |
|---|
| Formula |
C12H13N3O2
|
|---|
| Exact mass |
231.1008
|
|---|
| Mol weight |
231.25
|
|---|
| Structure |
|
|---|
| Simcomp |
|
|---|
| Class |
|
|---|
| Remark |
|
|---|
| Efficacy |
Antineoplastic, Alkylating agent |
|---|
| Target |
DNA |
|---|
| Interaction |
|
|---|
| Brite |
Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
L ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS
L01 ANTINEOPLASTIC AGENTS
L01A ALKYLATING AGENTS
L01AC Ethylene imines
L01AC02 Triaziquone
D07254 Triaziquone (INN)
Drug groups [BR:br08330]
Antineoplastic
DG01677 Alkylating agent
DG01723 Ethylene imine
D07254 Triaziquone
|
|---|
| Other DBs |
|
|---|
| LinkDB |
|
|---|
| KCF data |
ATOM 17
1 C2y C 25.6900 -19.1100
2 C2y C 25.6900 -17.7100
3 C5x C 26.8800 -17.0100
4 C2x C 28.1400 -17.7100
5 C2y C 28.1400 -19.1100
6 C5x C 26.8800 -19.8100
7 O5x O 26.8800 -21.2100
8 O5x O 26.8800 -15.6100
9 N1y N 24.5000 -19.8100
10 N1y N 24.5000 -17.0100
11 N1y N 29.3300 -19.8100
12 C1x C 30.7300 -19.8100
13 C1x C 30.0300 -21.0000
14 C1x C 23.1000 -19.8100
15 C1x C 23.8000 -21.0000
16 C1x C 23.8000 -15.7500
17 C1x C 23.1000 -17.0100
BOND 20
1 1 2 2
2 2 3 1
3 3 4 1
4 4 5 2
5 5 6 1
6 1 6 1
7 6 7 2
8 3 8 2
9 1 9 1
10 2 10 1
11 5 11 1
12 11 12 1
13 12 13 1
14 13 11 1
15 14 9 1
16 9 15 1
17 15 14 1
18 16 10 1
19 10 17 1
20 17 16 1
|
|---|
